SouthState Corp’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59K Hold
45
﹤0.01% 1002
2026
Q1
$1.25K Sell
45
-23
-34% -$591 ﹤0.01% 1000
2025
Q4
$1.48K Sell
68
-64
-48% -$1.26K ﹤0.01% 1045
2025
Q3
$2K Buy
132
+87
+193% +$1.08K ﹤0.01% 938
2025
Q2
$508 Sell
45
-2
-4% -$22 ﹤0.01% 1437
2025
Q1
$475 Buy
+47
New +$508 ﹤0.01% 1534

Other funds holding ROIV

SouthState Corp's ROIV Position: Q2 2026 in Review

SouthState Corp held its Roivant Sciences (ROIV) position steady in Q2 2026 at 45 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #1002.

SouthState Corp first reported a position in ROIV in Q1 2025 and has held it in 6 quarters since. The position peaked at $2K in Q3 2025. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • SouthState Corp held 45 shares of Roivant Sciences worth $1.59K as of Q2 2026.
  • SouthState Corp left its Roivant Sciences share count unchanged in Q2 2026.
  • Roivant Sciences made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #1002 holding.
  • SouthState Corp first reported a position in Roivant Sciences in Q1 2025 and has held it in 6 quarters since.
  • SouthState Corp's Roivant Sciences position peaked at $2K in Q3 2025.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.